Many patients may keep off lost pounds after stopping a GLP-1, US data suggests
Real-world data suggests weight loss durability post-GLP-1 drug discontinuationStudy suggests weight regain may be less common than clinical…
Exclusive: US FDA delays two drug reviews in new voucher program after safety, efficacy concerns
Reviews of Sanofi’s diabetes drug Tzield and Disc Medicine’s blood-disorder medicine bitopertin stalledTzield pushed back after adverse event…
US FDA requests removal of suicide warnings from weight-loss drug labels
Regulator asks drugmakers to remove warnings of suicidal thoughts from GLP-1 drugs’ labelsFDA finds no link between GLP-1…
Qatar and UAE to join U.S.-led effort to bolster technology supply chain
Qatar and UAE to officially join ‘Pax Silica’ within daysInitiative aims to move the Middle East toward a…
Trump says he may veto extension of Obamacare subsidies
Jan 11 (Reuters) – U.S. President Donald Trump said on Sunday he might veto legislation to extend federal…
Healthcare dealmakers head to San Francisco hoping for megamergers in 2026
Less antitrust scrutiny under Trump boosts M&A confidenceHealthcare M&A volume rose 56% in 2025, despite fewer transactionsJPMorgan health…
US FTC wins ruling blocking Edwards Lifesciences’ acquisition of JenaValve
Jan 9 (Reuters) – The U.S. Federal Trade Commission won a ruling on Friday blocking Edwards Lifesciences’ (EW.N),…
TPG in talks to buy UnitedHealth’s Optum UK unit, Sky News reports
Jan 6 (Reuters) – U.S. private equity firm TPG (TPG.O), opens new tab is close to acquiring UnitedHealth’s…
US builds case to retain measles elimination status as infections mount
US must prove current outbreaks unrelated to Texas to retain statusCDC using genetic analysis to assess outbreak linksGaps…
US FDA approves Vanda Pharmaceuticals’ motion sickness drug
Item 1 of 2 Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White…
Exclusive: Drugmakers raise US prices on 350 medicines despite pressure from Trump
Number of hikes rises from same time a year agoMedian list price increase is 4%, in line with…
Novo and Lilly cut prices of weight-loss drugs in China
Dec 29 (Reuters) – Novo Nordisk (NOVOb.CO), opens new tab and Eli Lilly (LLY.N), opens new tab are…